These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4416065)

  • 1. Ten years experience with fluoride in otosclerotic (otospongiotic) patients.
    Shambaugh GE; Causse J
    Ann Otol Rhinol Laryngol; 1974; 83(5):635-42. PubMed ID: 4416065
    [No Abstract]   [Full Text] [Related]  

  • 2. The possible value of sodium fluoride for inactivation of the otosclerotic bone lesion. Experimental and clinical studies.
    Shambaugh GE; Petrovic A
    Acta Otolaryngol; 1967 Apr; 63(4):331-9. PubMed ID: 6033657
    [No Abstract]   [Full Text] [Related]  

  • 3. Sodium fluoride for inactivation of the otosclerotic lesion. Present status.
    Shambaugh GE
    Arch Otolaryngol; 1969 Feb; 89(2):381-2. PubMed ID: 5763935
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical experience and experimental findings with sodium fluoride in otosclerosis (otospongiosis).
    Causse J; Chevance LG; Shambaugh GE
    Ann Otol Rhinol Laryngol; 1974; 83(5):643-7. PubMed ID: 4412470
    [No Abstract]   [Full Text] [Related]  

  • 5. New concepts in management of otospongiosis.
    Shambaugh GE; causse J; Petrovic A; Chevance LG; Valvassori GE
    Arch Otolaryngol; 1974 Dec; 100(6):419-26. PubMed ID: 4447481
    [No Abstract]   [Full Text] [Related]  

  • 6. Sodium fluoride and the otosclerotic lesion.
    House HP; Linthicum FH
    Arch Otolaryngol; 1974 Dec; 100(6):427-30. PubMed ID: 4447482
    [No Abstract]   [Full Text] [Related]  

  • 7. Fluoride therapy for osteoporotic lesions.
    Parkins FM
    Ann Otol Rhinol Laryngol; 1974; 83(5):626-34. PubMed ID: 4606556
    [No Abstract]   [Full Text] [Related]  

  • 8. The enzymatic mechanism of the otospongiotic disease and NaF action on the enzymatic balance.
    Causse JR; Uriel J; Berges J; Shambaugh GE; Bretlau P; Causse JB
    Am J Otol; 1982 Apr; 3(4):297-314. PubMed ID: 6177249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Otospongiosis: morphologic and microchemical investigation after NaF-treatment.
    Bretlau P; Hansen HJ; Causse J; Causse JB
    Otolaryngol Head Neck Surg; 1981; 89(4):646-50. PubMed ID: 6793977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of accurate cochlear reverse in otospongiosis. Value of the vocal Weber test.
    Causse J; Bel J; Michaux P; Canut Y; Tapon J
    Ann Otolaryngol Chir Cervicofac; 1971; 88(10):569-80. PubMed ID: 5135216
    [No Abstract]   [Full Text] [Related]  

  • 11. Experiments and experiences with sodium fluoride for inactivation of the otosclerotic lesion.
    Shambaugh GE; Sundar VS
    Laryngoscope; 1969 Oct; 79(10):1754-64. PubMed ID: 5345408
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of sodium fluoride on otosclerotic activity as determined by strontium.
    Linthicum FH; House HP; Althaus SR
    Ann Otol Rhinol Laryngol; 1973; 82(4):609-15. PubMed ID: 4721187
    [No Abstract]   [Full Text] [Related]  

  • 13. [Juvenile otosclerosis].
    Sicard F; Desjardins R
    Union Med Can; 1970 Sep; 99(9):1639-41. PubMed ID: 5527441
    [No Abstract]   [Full Text] [Related]  

  • 14. Fluoride therapy for cochlear otosclerosis? an audiometric and computerized tomography evaluation.
    Derks W; De Groot JA; Raymakers JA; Veldman JE
    Acta Otolaryngol; 2001 Jan; 121(2):174-7. PubMed ID: 11349772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effect of otosclerosis on bone conduction.
    Cole JM; Bartels LJ; Beresny GM
    Laryngoscope; 1979 Jul; 89(7 Pt 1):1053-60. PubMed ID: 449548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Content of fluoride and calcium in stapedial bone in otosclerosis].
    Konarska A
    Otolaryngol Pol; 1997; 51(2):183-90. PubMed ID: 9518331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The evaluation of results of the surgical treatment in patients with otosclerosis].
    Krzywdzińska M; Kukwa A; Siemińska J
    Otolaryngol Pol; 2002; 56(2):181-8. PubMed ID: 12094643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cochlear otospongiosis].
    Appaix A; Pech A
    Ann Otolaryngol Chir Cervicofac; 1969 Mar; 86(3):175-84. PubMed ID: 5769829
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies of sodium fluoride effects (a) on human otosclerotic bone (b) on prevention of experimental osteoporosis in rats (c) synergistic action with phosphates.
    Petrovic A; Shambaugh GE
    Acta Otolaryngol; 1968; 65(1):120-9. PubMed ID: 5657101
    [No Abstract]   [Full Text] [Related]  

  • 20. [Biological bases for a fluoride treatment of otospongiosis. Experimental and clinical results].
    Causse J; Chevance LG
    Ann Otolaryngol Chir Cervicofac; 1973 Mar; 90(3):139-60. PubMed ID: 4717370
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.